Interesting Take On Andrew Witty’s Tenure By Erika Kelton For Forbes..


It’s good to see at least one mainstream news outlet has the balls to publish the truth about CEO Andrew Witty’s tenure at the helm at GSK over the past decade- however I would like to see more discussion about the 3 Billion dollar fine for what it actually was: a whitewash and NOT justice for consumers or patients- or in the words of Whistle-Blower Greg Thorpe– a mere “gift to GSK“…

Also, Perhaps Erika Kelton (the author of this Forbes article) could further explain to the public, why so little of this Department of Justice complaint involved Paxil (Seroxat/Paroxetine)? Considering that Paxil (Seroxat) has been GSK’s most controversial drug, I would like to know why was the focus of the investigation on Advair (GSK’s least dangerous drug when compared to drugs like Paxil) and also why do the other whistle-blowers- recruited at the time- not speak out about the sham investigation and white-wash fine?

My e-mail is always open to information and discussion Erika (if you’re reading!). I have much more information about GSK than I have published on this blog- several whistle-blowers have contacted me over the years, and some of these stories haven’t even been covered in the news at all, or online even.

Anyhow, here’s her Forbes article…

(ps- most of the info in this article could be gleaned straight from my blog- as I have been documenting GSK for ten years now- and have often done deeper digging than most journalists)


http://www.forbes.com/sites/erikakelton/2016/03/24/with-andrew-wittys-departure-will-glaxosmithkline-say-goodbye-to-fraud/

 

Mar 24, 2016 @ 04:43 PM 3,930 views

With Andrew Witty’s Departure, Will GlaxoSmithKline Say Goodbye to Fraud?

Erika Kelton ,

Contributor

I write about whistleblower matters involving fraud and other issues.

GSK has made headlines during Witty’s tenure, but for all the wrong reasons.

The company should scratch internal prospects off the list.

Glaxo SmithKline recently announced that its CEO, Andrew Witty, will be out the door as of March 31, 2017 – a development many were expecting.

GSK has made headlines during Witty’s tenure, but for all the wrong reasons.

Glaxo needs to make major changes after CEO Andrew Witty (on right) leaves the company next year.

Corruption, bribery, illegal marketing, contaminated drugs and collusion are some of the “highlights” of Glaxo’s business practices that were revealed during Witty’s nine years at the helm.

Witty oversaw Glaxo’s “Hall of Shame” when the following entries were added:

A $3 billion payment to the US to settle whistleblower allegations leading to civil and criminal charges that the company had marketed a number of its top-selling drugs for unapproved uses that in many cases endangered patients’ lives and health. It is the largest healthcare fraud settlement ever paid. (My firm represented the leading whistleblowers.)

A $750 million payment to settle whistleblower allegations that led to civil and criminal liability for manufacturing contaminated drugs at its facility in Puerto Rico and selling them.

A $489 million fine by a Chinese court for bribery and corruption charges based on allegations its China division paid doctors to prescribe Glaxo’s drugs. (A record penalty for China.)

Accusations of bribing doctors to prescribe Glaxo’s drugs in at least 11 other countries: Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Poland, Qatar, Romania, Syria and United

Arab Emirates.

A fine of roughly $54.5 million by Britain’s Competition & Markets Authority for allegedly paying generic drug makers illegally to delay the launch of cheaper versions of Glaxo’s Seroxat, an antidepressant.

A fine of about $9 million imposed by India’s Competition Commission for allegedly colluding with Sanofi India in bidding to supply a meningitis vaccine to the government for Haj pilgrims.

That’s a record that won’t be missed.

On the bright side, Witty’s announced resignation provides an opportunity for Glaxo to clean up its act.

Glaxo reportedly is considering external as well as internal candidates for the top spot. The company should scratch internal prospects off the list.

Witty came up through the ranks and landed in the CEO office after more than 20 years of slogging his way up from management trainee. Although Witty surely knows the business well, he was also part of a culture that was not healthy. Only an outsider with great resolve has a chance of reshaping the business to respect compliant and ethical practices.

Given Glaxo’s recent history, the board of directors should ensure that Witty’s replacement does more than drive up profits. A dramatic cultural shift at GSK is long past due.

A good place to start would be to listen to employees when they blow the whistle internally, particularly given the billions the company has paid to resolve significant problems whistleblowers have exposed. Glaxo will find that being open to whistleblower concerns could be very profitable in more ways than one.

Erika Kelton is a whistleblower attorney and partner at Phillips & Cohen LLP. http://www.phillipsandcohen.com. Follow @Fraudmatters.

Published by

truthman30

An Ex-Seroxat User , here to bring a deeper awareness of the Scandal that is Seroxat .

3 thoughts on “Interesting Take On Andrew Witty’s Tenure By Erika Kelton For Forbes..”

  1. Erika Kelton and her so called whistleblowers are frauds, period.
    Kelton told me specifically in a letter that “Off label marketing is not fraud”.
    Her firm would not take this case until they found out I was right.
    Both her me too whistleblowers were terminated GSK employees and Matt Burke was terminated for off label promotion as a Regional Manager, forcing some 200 plus representatives under him to do the same.

    This was AFTER I went to the highest ranking people in the company, complaining of off label fraud and kickbacks.
    These clones of me used much of the same information I sent Kelton…only to file a separate case about 4 months AFTER I had to get some rookie counsel to represent me.
    Her version of the story and their statements are not only false and misleading but probably defamatory to my position on the case. The Department of Justice gave ME standing as first to file and my attorneys handled the award.
    The award was decreased to the minimum largely because her “me too” terminated clients were actually deemed ” planners and initiators ” of the Fraud.
    This was a 9 year joke, and that is the time it took the DOJ to decimate my complaint and reduce it from some 350 pages with 750 exhibits to some 80 pages or so of a huge quid pro quo to GSK.
    I have a lot more to say on this and it was largely Kelton and her boys inaction and lack of substance on the major drugs…Paxil, Imitrex, Zyban and Wellbutrin that the settlement was so paultry.
    The settlement amounted to 3 months of PROFIT for GSK. It makes me sick, and Kelton declares victory ? I call bullshit.

    Criminal actions no doubt occurred over these 9 years including an illegal seal from the public on the case….9 years !! Sara Bloom, Kelton’s buddy was lead investigator and seemingly spearheaded the Gift to GSK.
    I have questions as to the role of Eric Holder also in this whole charade.
    A GSK defense attorney became Attorney General 5 years into the case. He supposedly recused himself, but there are indications he had his moles in the DOJ putting the clamps on any criminal indictment…let alone the insanely low penalty. Hundreds of thousands of patients were killed or suffered…nothing done. A slap on the wrist. Holder is now back at the same law firm, DEFENDING GSK. Anyone smell the RAT ?
    I have a lot more intimate knowledge about all of this…and have already been threatened for coming forward.
    I was the ONLY whistle-blower who was wrongfully terminated for coming forward.
    So Erika until you can stop lying and putting lipstick on this pig of a case…that cost the taxpayers Tens… if not hundreds of millions of dollars…
    I suggest you keep your mouth shut and comply with my request to show how you really handled the information I first gave to you…when you would not file, and declared in writing that “OFF LABEL DETAILING IS NOT FRAUD”…. It certainly is, especially when people die because of statements made to physicians, even by your own so-called whistle blowers

    To Forbes …..
    If you want the truth about this whole incredible 9 year quid pro quo….I will give you the truth, and not in some self serving article put forth to generate business for a lawfirm.
    The article makes me want to puke. You will get the whole truth from me, not just what some me-too attorney wants you to believe.
    Truth man, why don’t you publish the letter to me from Kelton ? Says it all on her integrity and real role in the case on the “killer” off label promotion…not some innocuous promotion on Advair for mild asthma, which in most cases helped patients….which she lays claim to…..having nothing on Imitrex, Paxil, or Avandia. The really harmful drugs. A useless pawn, and I have the evidence, including HOW she got into the case, and it was not because of the DOJ at all initially.
    Get real Erica, you can’t hide the real truth on this Government Fraud forever. That is the bottom line.
    The truth will come out, and not in a few paragraphs here…sooner or later.
    Greg Thorpe

  2. One other note, Kelton insists that GSK listen to internal whistleblowers.
    Certainly I agree…however this is coming from an attorney and a lawfirm who would not listen to the only internal whistle-blower in the 3 Billion dollar gift.
    Maybe Erica should take a little of her own advice..instead of only listening to terminated employees, planners and initiators of the Fraud, then claiming THEY
    were the leading whistleblowers.

    They both secured good jobs outside the company and lived the good life for ten years….while I went through hell for reporting while employed, then was subject to wrongful termination after almost 25 years with the company.
    Really Erika…you can fool some of the people some of the time..as the saying goes.
    Matt Burke, your main bread and butter, as you know… would not even put his name on the complaint until I forced him to do so, or hit the road. Some hero ?
    Come clean, seriously…it is about more than generating business for your firm through false and misleading statements. Bottom line you and your clients only got in the way in this case, especially in settlement discussions. The truth hurts, huh ? If I am wrong Burke can reply….but he will not. He was grossly unjustly enriched and could be in prison, instead of living the good life off of my initial complaints.
    Greg Thorpe

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s